key: cord-0978273-bktoj8dl authors: Hosseini, Javid; Pourani, Mohammadreza; Mehregan, Reihaneh; Forouzanfar, Mohammad‐Mehdi; Robati, Reza M title: Frequency of COVID‐19 in acne patients treated with oral doxycycline: A retrospective cross‐sectional comparative study date: 2021-08-20 journal: J Cosmet Dermatol DOI: 10.1111/jocd.14403 sha: 2dd0f4ab710f4cb16ff3982b7e928f194e6c3008 doc_id: 978273 cord_uid: bktoj8dl nan To the Editor, Coronavirus disease 2019 (COVID-19) imposed a significant and notable burden of the disease on international health in the world. Many treatments have been proposed, and none of them have had an absolute efficacy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. 1, 2 Doxycycline is a second-generation tetracycline antibiotic that, as an anti-inflammatory agent, might diminish the inflammatory process related to COVID-19. 1, 3 We designed a retrospective cross-sectional study and extracted the acne patients' electronic data treated with oral doxycycline 100 mg twice daily for more than three months and also another Ivermectin, famotidine, and doxycycline: A suggested combinatorial therapeutic for the treatment of COVID-19 Real estimates of mortality following COVID-19 infection Doxycycline as potent inhibitor of covid-19 main protease: in-silico docking approach Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease Clinical outcomes of early treatment with doxycycline for 89 high-risk COVID-19 patients in long-term care facilities in New York